Catalyst Wire Dossier Catalyst Wire Dossier

Indacaterol/glycopyrronium

Indacaterol + glycopyrronium · Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Indacaterol/glycopyrronium, covering 2016-12-12 to 2019-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort [Phase 4]

See pricing